Physician

Ronald D Hart, MD

According to 2025 Medicare claims, Ronald Hart, MD (NPI: 1356442032) practices family practice in the Yuba City, CA market, with the plurality of this provider's patient population coming from Sutter, CA. Hart uses personal NPI as billing NPI and primary practice location at 95991-3207.

Hart's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 702 traditional Medicare patients, billed 11,112 HCPCS/CPT codes, and received $557,102 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 14,314 prescription claims across 661 beneficiaries totaling $2,883,407 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 738 claims. Open Payments data shows 227 records totaling $10,243. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $367,038 to $557,102. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,031,567 to $2,883,407. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $50,668 and ending at $41,837.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	725	7,809	$367,038
2016	734	6,483	$358,165
2017	822	7,407	$388,530
2018	785	7,540	$398,578
2019	768	7,526	$484,755
2020	753	9,442	$537,190
2021	860	9,159	$653,144
2022	819	9,095	$586,494
2023	691	11,246	$664,403
2024	702	11,112	$557,102

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	497	9,645	$1,031,567
2016	552	10,249	$1,186,533
2017	634	11,038	$1,143,036
2018	618	12,144	$1,475,513
2019	589	12,078	$1,267,676
2020	597	12,536	$1,619,961
2021	687	12,579	$1,619,472
2022	701	12,336	$2,098,733
2023	621	12,609	$2,718,864
2024	661	14,314	$2,883,407

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	271	990	$56,069
2016	257	965	$31,870
2017	263	851	$18,333
2018	300	923	$20,398
2019	294	919	$21,960
2020	320	979	$32,366
2021	397	1,093	$38,428
2022	356	1,122	$43,452
2023	256	926	$43,160
2024	190	738	$38,043

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	212	212	$131
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	639	3,095	$92
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	475	1,219	$70
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	577	2,983	$40
96372	Injection of drug or substance under skin or into muscle	155	398	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	471	27,761	$502,197
Ozempic	Semaglutide	394	13,576	$417,599
Repatha Sureclick	Evolocumab	228	11,894	$225,696
Kerendia	Finerenone	194	10,233	$215,577
Eliquis	Apixaban	153	10,250	$197,928

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	25	$10,853
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	13	114	$7,796
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	14	$2,075
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	22	41	$1,919
E0601	Continuous positive airway pressure (cpap) device	Y	11	60	$1,910

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	227	$10,243	Esperion Therapeutics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ronald D. Hart, MD?

Tedicare shows public-source Medicare data for Ronald D. Hart, MD (NPI 1356442032), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ronald D. Hart, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ronald D. Hart, MD?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Ronald D. Hart, MD have Open Payments data?

Ronald D. Hart, MD has 227 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.